Density functional molecular study on the full conformational space of the S-4-(2-hydroxypropoxy)carbazol fragment of carvedilol (1-(9H-carbazol-4-yloxy)-3-[2-(2-methoxyphenoxy)ethylamino]-2-propanol) in vacuum and in different solvent media

被引:12
作者
Almeida, DRP
Pisterzi, LF
Chass, GA
Torday, LL
Varro, A
Papp, JG
Csizmadia, MG
机构
[1] Univ Toronto, Dept Chem, Lash Miller Labs, Toronto, ON M5S 3H6, Canada
[2] Velocet Commun Inc, Toronto, ON M5G 2E8, Canada
[3] Univ Szeged, Hungarian Acad Sci, Dept Pharmacol & Pharmacotherapy, H-6701 Szeged, Hungary
[4] Univ Szeged, Hungarian Acad Sci, Div Cardiovasc Pharmacol, H-6701 Szeged, Hungary
关键词
D O I
10.1021/jp021253c
中图分类号
O64 [物理化学(理论化学)、化学物理学];
学科分类号
070304 ; 081704 ;
摘要
Density functional theory (DFT) conformational analysis was carried out on the potential energy hypersurface (PEHS) of the carbazole-containing molecular fragment, S-4-(2-hydroxypropoxy)-carbazol, of the chiral cardiovascular drug molecule carvedilol, (1-(9H-carbazol-4-yloxy)-3-[2-(2-methoxy-phenoxy)ethylamino]-2-propanol). The PEHS was computed in vacuum, chloroform, ethanol, DMSO, and water at the B3LYP/6-31G(d) level of theory. The carbazole ring system was confirmed to be planar, and the resultant PEHS in vacuum contained 19 converged minima, of which the global minima possessed a conformation with chi(1), chi(2), and chi(3) in the anti position and chi(10) in the g position. Conformer stability for the S-4-(2-hydroxypropoxy)carbazol PEHS was influenced by intramolecular hydrogen bonding. Tomasi PCM reaction-field calculations revealed that the lowest SCF energies, relative conformer energies, and solvation free energies (DeltaG (solvation)) for the S-4-(2-hydroxypropoxy)carbazol PEHS were in protic solvents, ethanol and water, because of the larger hydrogen bond donor values of these solvents, which aid in stabilization of the dipole moment created by the carbazole ring system and the oxygen and nitrogen atoms. However, solvent effects contributed most significantly to the stabilization of S-4-(2-hydroxypropoxy)carbazol conformers that contained no internal hydrogen bonding, whereas solvent effects were not as important for conformers that contained intramolecular hydrogen bonding.
引用
收藏
页码:10423 / 10436
页数:14
相关论文
共 30 条
[1]   REGARDING A GENERALIZED SCALE OF SOLVENT POLARITIES [J].
ABBOUD, JL ;
TAFT, RW .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1977, 99 (25) :8325-8327
[2]  
BAGNO A, 2002, SOLVATION SOLVENT EF, P20
[3]   Prospects in computational molecular medicine:: a millennial mega-project on peptide folding [J].
Berg, MA ;
Chasse, GA ;
Deretey, E ;
Füzéry, AK ;
Fung, BM ;
Fung, DYK ;
Henry-Riyad, H ;
Lin, AC ;
Mak, ML ;
Mantas, A ;
Patel, M ;
Repyakh, IV ;
Staikova, M ;
Salpietro, SJ ;
Tang, TH ;
Vank, JC ;
Perczel, A ;
Csonka, GI ;
Farkas, Ö ;
Torday, LL ;
Székely, Z ;
Csizmadia, IG .
JOURNAL OF MOLECULAR STRUCTURE-THEOCHEM, 2000, 500 :5-58
[4]   β-blockade therapy in chronic heart failure:: Diastolic function and mitral regurgitation improvement by carvedilol [J].
Capomolla, S ;
Febo, O ;
Gnemmi, M ;
Riccardi, G ;
Opasich, C ;
Caporotondi, A ;
Mortara, A ;
Pinna, G ;
Cobelli, F .
AMERICAN HEART JOURNAL, 2000, 139 (04) :596-608
[5]  
Carlson, 1999, J Cardiovasc Pharmacol Ther, V4, P205, DOI 10.1177/107424849900400402
[6]   Ab initio study of solvated molecules: A new implementation of the polarizable continuum model [J].
Cossi, M ;
Barone, V ;
Cammi, R ;
Tomasi, J .
CHEMICAL PHYSICS LETTERS, 1996, 255 (4-6) :327-335
[7]  
Feuerstein G, 1998, Adv Pharmacol, V42, P611
[8]   Novel mechanisms in the treatment of heart failure: Inhibition of oxygen radicals and apoptosis by carvedilol [J].
Feuerstein, G ;
Yue, TL ;
Ma, XL ;
Ruffolo, RR .
PROGRESS IN CARDIOVASCULAR DISEASES, 1998, 41 (01) :17-24
[9]   A POTENT ANTIOXIDANT, SB209995, INHIBITS OXYGEN-RADICAL-MEDIATED LIPID-PEROXIDATION AND CYTOTOXICITY [J].
FEUERSTEIN, R ;
YUE, TL .
PHARMACOLOGY, 1994, 48 (06) :385-391
[10]  
FORESMAN JB, 1996, EXPLORING CHEM ELECT, P237